Enrollment Optimization Inteliquet specializes in cancer trial patient matching and sponsor-to-center access, enabling faster enrollment and improved screening accuracy. As an IQVIA business, there is a clear opportunity to cooperatively sell to pharma sponsors and cancer centers nationwide, offering a streamlined path from trial selection to patient enrollment and measurable recruitment improvements.

EMR Integration The company has a track record addressing EMR interrogation challenges and optimizing data capture for trial eligibility. Target health systems, CROs, and sponsors with complex EMR environments by positioning Inteliquet as the partner to accelerate patient identification through interoperable data workflows and robust data handling.

Strategic Partnerships Past collaborations with Life Sciences PA and the National Cancer Institute signal strong partnership capabilities. Expand within the IQVIA ecosystem to co-develop solutions and cross-sell to pharma sponsors and research networks, leveraging joint capabilities to improve clinician decision support and patient access.

Growth and Scale Recent leadership hires in life sciences and finance indicate a scaling trajectory and readiness to support larger multi-site studies. Position to mid-market pharma and oncology networks that require enterprise-grade governance, reporting, and scalable enrollment programs across diverse centers.

Competitive Positioning Inteliquet occupies a focused niche in cancer trial recruitment and patient matching amid larger analytics players. Highlight differentiated value through specialized, sponsor-to-center enrollment workflows and high-touch support, while pursuing mid-sized cancer centers and sponsors as early adopters within a broader IQVIA-backed ecosystem.